Baker Brothers Advisors - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,302,000
+12.3%
363,9800.0%0.01%
+25.0%
Q4 2020$2,049,000
-12.9%
363,980
-10.0%
0.01%
-11.1%
Q3 2020$2,352,000
-23.2%
404,200
-4.9%
0.01%
-35.7%
Q2 2020$3,064,000
+54.0%
425,0000.0%0.01%
+16.7%
Q1 2020$1,989,000
-41.7%
425,0000.0%0.01%
-33.3%
Q4 2019$3,409,000
+16.6%
425,0000.0%0.02%
-10.0%
Q3 2019$2,924,000
-17.1%
425,0000.0%0.02%
-16.7%
Q2 2019$3,528,000
-16.5%
425,0000.0%0.02%
-11.1%
Q1 2019$4,225,000
+30.0%
425,0000.0%0.03%0.0%
Q4 2018$3,251,000
-56.1%
425,0000.0%0.03%
-44.9%
Q3 2018$7,404,000425,0000.05%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders